January 21, 2022

The Japan Herald

About Japan, Global Green Energy and Space Market

Global Interferon Alpha-2a Biosimilar Market Research Report 2022 Professional Edition

4 min read

The global Interferon Alpha-2a Biosimilar market was valued at 297.46 Million USD in 2021 and will grow with a CAGR of 11.78% from 2021 to 2027, based on newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.The global average price of Interferon Alpha-2a Biosimilar is in the decreasing trend, from 186.78 USD/Unit in 2013 to 64.67 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years. The classification of Interferon Alpha-2a Biosimilar includes ordinary type and long-lasting type, and the proportion of ordinary type in 2017 is about 64%, and the proportion is in increasing trend from 2013 to 2017. Interferon Alpha-2a Biosimilar is widely used for hepatitis C, hepatitis B and other diseases. The most proportion of Interferon Alpha-2a Biosimilar is used for hepatitis C, and the proportion in 2017 is 46%. Europe is the largest supplier of Interferon Alpha-2a Biosimilar, with a production market share nearly 70% in 2017. South America is the largest consumption place, with a consumption market share nearly 26% in 2017. Following South America, Europe is the second largest consumption place with the consumption market share of 22%. Market competition is not intense. Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

By Market Verdors:

 

  • Roche
  • Biosidus
  • Zydus Cadila
  • Nanogen
  • Amega Biotech
  • Rhein Minapharm Biogenetics
  • PROBIOMED
  • 3sbio

By Types:

  • Long-lasting Type
  • Ordinary Type

By Applications:

  • Hepatitis C
  • Hepatitis B

Key Indicators Analysed

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

  • To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
  • Assess the production processes, major issues, and solutions to mitigate the development risk.
  • To understand the most affecting driving and restraining forces in the market and its impact in the global market.
  • Learn about the market strategies that are being adopted by leading respective organizations.
  • To understand the future outlook and prospects for the market.
  • Besides the standard structure reports, we also provide custom research according to specific requirements

Table of content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Interferon Alpha-2a Biosimilar Revenue

1.4 Market Analysis by Type

1.4.1 Global Interferon Alpha-2a Biosimilar Market Size Growth Rate by Type: 2021 VS 2027

1.4.2 Long-lasting Type

1.4.3 Ordinary Type

1.5 Market by Application

1.5.1 Global Interferon Alpha-2a Biosimilar Market Share by Application: 2022-2027

1.5.2 Hepatitis C

1.5.3 Hepatitis B

1.6 Study Objectives

1.7 Years Considered

1.8 Overview of Global Interferon Alpha-2a Biosimilar Market

1.8.1 Global Interferon Alpha-2a Biosimilar Market Status and Outlook (2016-2027)

1.8.2 North America

1.8.3 East Asia

1.8.4 Europe

1.8.5 South Asia

1.8.6 Southeast Asia

1.8.7 Middle East

1.8.8 Africa

1.8.9 Oceania

1.8.10 South America

1.8.11 Rest of the World

2 Market Competition by Manufacturers

2.1 Global Interferon Alpha-2a Biosimilar Production Capacity Market Share by Manufacturers (2016-2021)

2.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Interferon Alpha-2a Biosimilar Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Interferon Alpha-2a Biosimilar Production Sites, Area Served, Product Type

3 Sales by Region

3.1 Global Interferon Alpha-2a Biosimilar Sales Volume Market Share by Region (2016-2021)

3.2 Global Interferon Alpha-2a Biosimilar Sales R

CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414

Similar Reports:

Global Interferon Alpha-2a Biosimilar Market Outlook 2022

Interferon Alpha-2b Biosimilar Market Size, Share – Global Outlook and Forecast 2021-2027

Global Interferon Alpha-2a Biosimilar Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global and Regional Interferon Alpha-2a Biosimilar Industry Status and Prospects Professional Market Research Report Standard Version

Leave a Reply

Your email address will not be published. Required fields are marked *